QPharma Launches Digital Sampling Platform for Medical Congresses

New platform integrates technology and personal support to transform healthcare provider engagement at conferences.

Published on Feb. 21, 2026

Got story updates? Submit your updates here. ›

QPharma, a leader in compliant HCP engagement and sampling solutions, has launched a next-generation digital sampling experience that combines intuitive technology with personal representative support. The platform, themed 'Engage & Access', was demonstrated at a recent national medical congress, proving that digital innovation and regulatory discipline can coexist. The initiative merges an on-site kiosk interface and a secure digital 'Briefcase' microsite to enable quick, compliant sample requests and provide HCPs access to product data, formulary resources, and pharmaceutical representatives.

Why it matters

Medical congresses create valuable opportunities for scientific dialogue, but the process of getting samples into physicians' hands often lags behind. Traditional follow-ups, such as post-conference Direct-to-Practitioner (DTP) requests, can result in missed opportunities once attendees return to their practices. QPharma's new platform aims to close this gap by enabling HCPs to request samples and connect with representatives in the moment, while ensuring compliance remains a top priority.

The details

The 'Engage & Access' platform features an on-site kiosk interface that enables quick, intuitive sample requests with guidance from an on-site pharmaceutical representative. It also includes an on-site 'Briefcase' microsite, a secure digital hub where HCPs can explore product data, request samples, connect with representatives, and access formulary resources. The program not only met all PDMA and 21 CFR Part 203 and Part 11 requirements, but also passed Legal, Medical, and Regulatory (LMR) review, an internal approval process recognized for its depth.

  • The platform was demonstrated at a recent national medical congress.

The players

QPharma

A leader in compliant HCP engagement and sampling solutions.

Jitesh Rohatgi

Chief Technology Officer at QPharma.

Ann Rose Galang

Vice President Innovation at QPharma.

Judy Fox

Director of Compliance at QPharma.

Got photos? Submit your photos here. ›

What they’re saying

“Getting a program of this nature through LMR review proved that innovation and compliance can advance together. Every question was addressed transparently, and every solution was built within regulatory boundaries.”

— Jitesh Rohatgi, Chief Technology Officer (businesswire.com)

“The results demonstrate how technology can bridge the gap between education and action. Together, we created a frictionless, compliant sampling experience that enhances both engagement and patient care.”

— Ann Rose Galang, Vice President Innovation (businesswire.com)

“Every kiosk interaction required a pharmaceutical representative. It ensured education came first, compliance never wavered, and technology made engagement effortless.”

— Judy Fox, Director of Compliance (businesswire.com)

What’s next

QPharma plans to extend the 'Engage & Access' experience to future events and therapeutic areas, reflecting a growing trend toward digitally enabled, human-guided engagement supported by strong compliance infrastructure.

The takeaway

QPharma's new digital sampling platform demonstrates how technology and personal interaction can be combined to create a frictionless, compliant experience that enhances healthcare provider engagement and supports patient care, while navigating the complex regulatory landscape of the pharmaceutical industry.